Shares of Novo Nordisk (NYSE: NVO) fell on Monday, finishing down 5.6%. The drop comes as the S&P 500 and the Nasdaq ...

Discover why Centrus’ cash strength, rising demand, and unique US enrichment position drive a speculative buy outlook.

Walmart reported their fiscal Q3 ’26 financial results last Thursday morning, November 20th, ’25, and the stock bounced ...

Big Tech helps push stock indexes higher on Monday after last week's declines.

Here are the top stories to read ahead of Monday's trading: ...

Earnings reports can swing fortunes overnight, and we saw a study in contrasts last week Nvidia (NASDAQ:NVDA) unveiled its ...

The Dow Jones index and the Nasdaq rose on the stock market today, with Tesla and Alphabet among AI stocks jumping. Health ...

HighPeak Energy stock is set to benefit from restructured leadership and operations and aims for stronger cash flow. Click ...

Iovance Biotherapeutics management is shifting focus from patient infusions to revenue as the primary performance metric.

Novo Nordisk's stock fell after semaglutide's Alzheimer's news. Click here for how strong fundamentals and growth catalysts ...

The Disney Destiny embarked on its maiden voyage out of Florida over the weekend. It's the seventh vessel in the ...

Novo Nordisk stock share price today fell after the company announced that semaglutide, used in Ozempic and Wegovy, failed to ...